Effectiveness, safety, and Economic Comparison of Two Inhaled Epoprostentol Products (Flolan and Veletri) in Cardiothoracic Surgery Patients.

Jaclyn M HawnMatthew WanekSeth R BauerMahmoud A AmmarSteven InslerAhmad AdiHeather Torbic

Published in: The Annals of pharmacotherapy (2018)

Inhaled Veletri was demonstrated to be non-inferior to inhaled Flolan when comparing change in PaO2/FiO2 ratio 1 hour post -therapy initiation,and inhaled Veletri was an acceptable alternative to inhaled Flolan in a cardiothoracic surgery patient population.

Keyphrases

cystic fibrosis
minimally invasive
end stage renal disease
coronary artery bypass
ejection fraction
newly diagnosed
chronic kidney disease
blood pressure
peritoneal dialysis
case report
surgical site infection
mesenchymal stem cells
patient reported
smoking cessation
replacement therapy